BioSpace News Archive

- As reported, full fiscal year revenues of $15.983 billion increased 32.2 percent.

Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019

US Specialty Care achieved accreditation through the Accreditation Commission for Health Care (ACHC) for Specialty Pharmacy Services on August 28, 2018.

Avanos Medical, Inc. today reported third quarter 2018 results and affirmed its full-year 2018 adjusted diluted earnings per share outlook of $1.75 to $1.90.

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a definitive agreement to acquire VIBATIV® from Theravance Biopharma.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a commercial biotechnology company, today provided an update on its third quarter 2018 results and recent business activities.

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that the VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS® 5600 Integrated System1.

Spectrum Science Communications today announced that Michelle Gross will be stepping into the role of President of the agency.

[06-November-2018] DUBLIN , Nov. 6, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today announced the sale of its proprietary antibiotic, VIBATIV ® (telavancin), to Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on the delivery of high-quality prescription brands to improve patient care. Unde

MediPath Pathology Lab is committed to providing top-of-line service to their clients by constantly sourcing the most innovative solutions that improve patient care.